Lutathera 370 MBq/mL solution for infusion
*Company:
Novartis Ireland LimitedStatus:
UpdatedLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 11 November 2025
File name
Lutathera_REG PIL_PF25-0023_03.11.2025_clean_IPHA.pdf
Reasons for updating
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 2 - interactions with other medicines, food or drink
- Change to section 2 - pregnancy, breast feeding and fertility
- Change to section 3 - how to take/use
- Change to section 4 - possible side effects
Updated on 11 November 2025
File name
Lutathera_REG SPC_PF25-0023_03.11.2025_clean_IPHA.pdf
Reasons for updating
- Change to section 4.2 - Posology and method of administration
- Change to section 4.8 - Undesirable effects
- Change to section 5.1 - Pharmacodynamic properties
- Change to section 5.2 - Pharmacokinetic properties
- Change to section 11 - Dosimetry
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 01 July 2024
File name
Lutathera_REG PIL_PF24-0092_clean_IPHA_May_2024.pdf
Reasons for updating
- Change to section 3 - how to take/use
Updated on 01 July 2024
File name
Lutathera_REG SPC_PF24-0092_clean_ IPHA_May2024.pdf
Reasons for updating
- Change to section 6.6 - Special precautions for disposal and other handling
- Change to section 12 - Instructions for preparation of radiopharmaceuticals
Legal category:Product subject to medical prescription which may not be renewed (A)
File name
A406223 Novartis Lutathera A5 Patient Booklet-d5_Final approved Patient Guide.pdf
Reasons for updating
- Add New Doc
Updated on 17 October 2023
File name
Lutathera_REG PIL_PF23-0153_19.09.2023_clean_IPHA.pdf
Reasons for updating
- New PIL for new product
Updated on 17 October 2023
File name
Lutathera_REG SPC_PF22-0137_20.04.2023_clean_IPHA.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Novartis Ireland Limited
Address:
Vista Building, Elm Park Business Park, Merrion Road, Dublin 4, IrelandMedical Information E-mail:
medinfo.dublin@novartis.comTelephone:
+353 1 2601255Fax:
+353 1 2601263